Literature DB >> 18752633

Prognostic role of global DNA-methylation and histone acetylation in pT1a clear cell renal carcinoma in partial nephrectomy specimens.

D Minardi1, G Lucarini2, A Filosa3, G Milanese1, A Zizzi2, R Di Primio2, R Montironi3, G Muzzonigro1.   

Abstract

Surgery is the main treatment for renal cell carcinoma (RCC); nephron sparing surgery can be performed as a treatment of choice for small peripheral lesions. Epigenetics configures a new entity that regulates gene expression throughout methylation, acetylation and chromatin remodelling. In addition to silencing as a result of mutations, loss of heterozygosity, or classic genetic events, epigenetic modification symbolizes essential events during carcinogenesis and tumour development. We investigated global methylation and histone acetylation expression in a series of small conventional clear cell renal carcinomas (i.e. less than 5 cm) (pT1a) treated with partial nephrectomy, to assess their possible role as diagnostic biomarkers. A total of 54 patients with conventional single RCC were selected and treated with partial nephrectomy; they were followed up to 186 months. Immunohistochemistry was performed on paraffin-embedded sections, using anti-5-methylcytosine (5mc) and anti-Acetyl-Histone H3 (Lys 9). Our results confirm that the mean percentage of global cellular methylation in tumoural tissue was significantly higher compared to healthy peritumoural tissue, whereas the mean percentage of histone cellular acetylation in tumoural tissue was significantly lower. The percentage of methylation was significantly higher in grades 3 and 4 (P = 0.033), whereas the percentage of histone acetylation was significantly lower (P = 0.023), suggesting therefore that these markers could correlate with tumour aggressiveness in pT1a RCC. On univariate analysis of patient survival in relation to the different considered factors, Fuhrman grade was the most important survival factor. These epigenetic markers can give us interesting information about chromatin remodelling in RCCs; the percentage of global methylation increases with increasing Fuhrman grade, whereas histone acetylation decreases with increasing grade in small RCC; our results suggest that global hypermethylation and histone hypoacetylation can be assumed to be an early event in RCC and to correlate with tumour aggressiveness.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752633      PMCID: PMC6512382          DOI: 10.1111/j.1582-4934.2008.00482.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  22 in total

1.  Environmental chemical exposures and human epigenetics.

Authors:  Lifang Hou; Xiao Zhang; Dong Wang; Andrea Baccarelli
Journal:  Int J Epidemiol       Date:  2011-12-13       Impact factor: 7.196

2.  Detection of global hypermethylation in well-differentiated thyroid neoplasms by immunohistochemical (5-methylcytidine) analysis.

Authors:  S Keelawat; P S Thorner; S Shuangshoti; A Bychkov; N Kitkumthorn; P Rattanatanyong; W Boonyayothin; U Poumsuk; P Ruangvejvorachai; A Mutirangura
Journal:  J Endocrinol Invest       Date:  2015-03-05       Impact factor: 4.256

3.  Abnormal methylation status of FBXW10 and SMPD3, and associations with clinical characteristics in clear cell renal cell carcinoma.

Authors:  Jinyou Wang; Jian Li; Jun Gu; Jian Yu; Shicheng Guo; Yao Zhu; Dingwei Ye
Journal:  Oncol Lett       Date:  2015-09-16       Impact factor: 2.967

4.  Associations between arsenic exposure and global posttranslational histone modifications among adults in Bangladesh.

Authors:  Yana Chervona; Megan N Hall; Adriana Arita; Fen Wu; Hong Sun; Hsiang-Chi Tseng; Eunus Ali; Mohammad Nasir Uddin; Xinhua Liu; Maria Antonietta Zoroddu; Mary V Gamble; Max Costa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-12       Impact factor: 4.254

Review 5.  Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma.

Authors:  Swathi Ramakrishnan; Roberto Pili
Journal:  Cancer J       Date:  2013 Jul-Aug       Impact factor: 3.360

Review 6.  DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.

Authors:  Javier C Angulo; Jose I López; Santiago Ropero
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

7.  Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.

Authors:  Caroline Y Hu; Davoud Mohtat; Yiting Yu; Yi-An Ko; Niraj Shenoy; Sanchari Bhattacharya; Maria C Izquierdo; Ae Seo Deok Park; Orsolya Giricz; Nishanth Vallumsetla; Krishna Gundabolu; Kristin Ware; Tushar D Bhagat; Masako Suzuki; James Pullman; X Shirley Liu; John M Greally; Katalin Susztak; Amit Verma
Journal:  Clin Cancer Res       Date:  2014-06-10       Impact factor: 12.531

Review 8.  The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments.

Authors:  Javier C Angulo; Claudia Manini; Jose I López; Angel Pueyo; Begoña Colás; Santiago Ropero
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

9.  LINE-1 methylation levels in leukocyte DNA and risk of renal cell cancer.

Authors:  Linda M Liao; Paul Brennan; Dana M van Bemmel; David Zaridze; Vsevolod Matveev; Vladimir Janout; Hellena Kollarova; Vladimir Bencko; Marie Navratilova; Neonila Szeszenia-Dabrowska; Dana Mates; Nathaniel Rothman; Paolo Boffetta; Wong-Ho Chow; Lee E Moore
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

10.  The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancer.

Authors:  Kenneth J O'Byrne; Martin P Barr; Steven G Gray
Journal:  Cancers (Basel)       Date:  2011-03-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.